Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ZBIO compared with MBX: revenue, margins and what each company keeps, and the suppliers and customers both name
ZBIO
Zenas BioPharma, Inc.
Change
Mkt cap
Revenue
Revenue
MBX
MBX Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ZBIO
Zenas BioPharma, Inc.
vs
MBX
MBX Biosciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
ZBIO
with
MBX
No shared trading history for ZBIO and MBX.
Shared co-movers
3
with ZBIO
with MBX
SYRE
Spyre Therapeutics, Inc.
r 0.36
r 0.30
ORKA
Oruka Therapeutics, Inc.
r 0.35
r 0.27
IMVT
Immunovant, Inc.
r 0.36
r 0.26
ZBIO, solid
MBX, hatched
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
ZBIO
Zenas BioPharma, Inc.
Change
26.08
▼
−8.37%
· post 25.00
Mkt cap
$1.7B
Revenue
$10M
Q3 FY26
MBX
MBX Biosciences, Inc.
Change
48.43
▼
−7.72%
· post 48.43
Closed
Nov 5 '26
Mkt cap
$2.3B
Revenue
—
vs
Compare
Closed
Nov 5 '26
ZBIO
Zenas BioPharma, Inc.
vs
MBX
MBX Biosciences, Inc.
26.08
▼
−8.37%
post 25.00
Price
48.43
▼
−7.72%
post 48.43
$1.7B
Mkt cap
$2.3B
Q3 FY26
$10M
Revenue
—
Change
Change
ZBIO
26.08
▼
−8.37%
vs
MBX
48.43
▼
−7.72%
Closed
Nov 5 '26